Regular and Young Investigator Award Abstracts 2022
DOI: 10.1136/jitc-2022-sitc2022.1123
|View full text |Cite
|
Sign up to set email alerts
|

1123 Preclinical activity and safety profile or JANX008, a novel EGFR-targeting tumor-activated T cell engager for treatment of solid tumors

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles